Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Neuroinfectious diseases: Emerging challenges for infectious disease specialists6 July, 2020A 22-year retrospective study of inquiries on neuroinfectious diseases in the Emerging Infections Network (EIN) reveals the emerging challenges faced in the infectious disease community,... -
The role of high-dose levofloxacin in the treatment of community-onset bacteraemia29 June, 2020Associate Professor Ching-Chi Lee Attending Physician, Center of Clinical Medical Research and Department of Internal Medicine, National Cheng Kung University Hospital, Taiwan The... -
‘Super immunity’: How bats carry viruses without getting sick1 June, 2020Bats are known for their ability to carry a number of high-profile viruses such as the Ebola virus, Nipah virus, and coronavirus.1 While these viruses can cause severe and deadly diseases in... -
Pathogen-specific strategies may improve prevention efforts of CLABSIs7 May, 2020Scientists from the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention analysed central-line–associated bloodstream infection... -
Status of Levofloxacin in the perspective of HAP/VAP Guidelines17 April, 2020Professor Shi Yi Professor, Chief Physician, Doctoral Supervisor, Postdoctoral Supervisor Fellow of the American College of Chest Physicians Standing Committee Member of Respiratory... -
Managing pneumonia with artificial intelligence (AI)8 April, 2020As artificial intelligence (AI) becomes increasingly important in the global healthcare system, more scientists are using AI to improve public health efforts in the fight against infectious... -
First flu strain encountered sets the course for subsequent immune response17 March, 2020Scientists from the University of California, Los Angeles (UCLA) and the University of Arizona have found that the ability of an individual to fight flu is influenced by the strain first... -
Infectious diseases (ID) consultation increases survival by fourfold5 March, 2020Yet another study demonstrated the importance of infectious diseases (ID) consultation in improving the survival rate of a patient with septicaemia.1 This time, lack of ID consultation was... -
Is diabetes a risk factor for herpes zoster?20 February, 2020In line with the results from a previous meta-analysis that evaluated several studies on herpes zoster (HZ),1 the findings from a literature review by a group of researchers in France demonstrate... -
Levofloxacin reduces mortality rate in myeloma4 February, 2020A randomised placebo-controlled trial that aimed to tackle early morbidity and mortality in myeloma (TEAMM) revealed that prophylactic levofloxacin reduces the risk of infection and death in...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
The role of high-dose levofloxacin in the treatment of community-onset bacteraemia -
Status of Levofloxacin in the perspective of HAP/VAP Guidelines -
Clinical practice of community-acquired pneumonia (CAP) in emergency department -
Application of quinolones in the emergency department -
Combination Therapy of Medications from the Perspective of PK / PD -
Antibiotic resistance and the role of high-dose, short-course levofloxacin in the treatment of pneumonia -
Sitafloxacin roles in the treatment of bacterial infections -
Interview on diagnosis and treatment of non-tuberculous mycobacterium infection -
High-dose, short-course levofloxacin versus conventional regimen for acute bacterial infection -
Recent update in the management of chronic obstructive pulmonary disease – an Asian perspective